AUA 2022 VL

Comparison of Dual Lumen Versus Single Lumen Flexible Ureteroscopes in Proximal Ureteral and Renal Stone Management - Rohit Bhatt

Details
Rohit Bhatt presents results from this randomized study that compared single lumen versus dual lumen flexible ureteroscopy laser lithotripsy to determine which method would provide the most efficient and effective stone clearance. Biographies: Rohit Bhatt, BS, MS4, UCI Urology LIFT Fellow, Department of Urology, University of California, Irvine Related Content: Is flexible ureteroscopy and laser l...

Thermal Effects of the Super-Pulse Thulium Fiber Laser During Ureteral Stone Laser Lithotripsy: An In Vivo Porcine Study - Kalon Morgan

Details
Kalon Morgan presents the results of an assessment of intra-ureteral temperature changes during thulium laser lithotripsy and an in-vivo porcine ureter. Biographies: Kalon Morgan, BS, LIFT Research Fellow, Department of Urology, University of California, Irvine Related Content: AUA 2022: Ureteroscopic Thulium Laser Lithotripsy Augmented with a Novel Reverse Thermal Hydrogel in an In-Vivo Porcine M...

Automated CT-based Stone Volume Determination: An Artificial Intelligence Algorithm to Calculate Kidney Stone Volume - Kalon Morgan

Details
Kalon Morgan presents results from a project entitled Automated CT-Based Stone Volume Determination: An Artificial Intelligence Algorithm to Calculate Kidney Stone Volume. Mr. Morgan explains how an AI deep learning algorithm was used to segment renal stone volumes in this study. Biographies: Kalon Morgan, BS, LIFT Research Fellow, Department of Urology, University of California, Irvine Related Co...

Comparison of Superpulse Thulium Fiber Laser vs. Holmium Laser for Ablation of Renal Calculi in an In Vivo Porcine Model - Andyshea Afyouni

Details
Andrew Afyouni presents results from a study comparing the effectiveness and efficiency of the Superpulse Thulium Fiber Laser versus the standard Holmium laser for ureteroscopic dusting of renal stones in an in vivo porcine model. Biographies: Andyshea (Andrew) Afyouni, MD Candidate, Department of Urology, University of California, Irvine Related Content: EAU 2019: Prospective Clinical Study on Su...

A Probing Conversation on Prostate Cancer Diagnosis and the Potential of Liquid Biopsies and Polygenic Risk Scores - Sanoj Punnen

Details
Matthew Cooperberg warmly welcomes Sanoj Punnen, to discuss the complexities surrounding the prediagnostic space for men with elevated PSA levels and the challenging decision of whether to pursue a biopsy. Dr. Punnen highlights the limitations of PSA as a screening tool, emphasizing the emerging role of liquid biopsy markers and MRI in this area. They both recognize the significance of integrating...

The Controversy Over Radical Cystectomy for N1 and N2 Bladder Cancer: Experts Weigh In - Brant Inman & Yair Lotan

Details
Kamal Pohar moderates a conversation with Brant Inman and Yair Lotan. The experts delve into the role of radical cystectomy for clinical N1 or N2 bladder cancer. Dr. Inman advocates for cystectomy combined with lymph adenectomy after systemic therapy, emphasizing its potential for better patient outcomes. Dr. Lotan, however, raises concerns about the heterogeneity in node positivity and the limita...

Upper Tract Urothelial Carcinoma Highlights - Nima Almassi

Details
Nima Almassi joins Sam Chang to discuss some exciting abstract highlights about upper tract urothelial carcinoma presented at the AUA 2022. Dr. Almassi shares key takeaways on studies regarding nephron-sparing treatments for upper tract disease. He also discusses research on the increasing administration of intracavitary or topical treatment. The pair also discuss new developments in the field, in...

Adjuvant Treatment for Men with Prostate Cancer with High Risk of Metastasis, the ERADICATE Study - Ashley Ross

Details
In this discussion, Alicia Morgans and Ashley Ross discuss men in the adjuvant setting with the highest risk of prostate cancer metastasis by genomic stratification. They focus their discussion on Decipher molecular testing after prostatectomy and the Phase III ERADICATE study. The ERADICATE trial was presented at this year's ASCO meeting. Biographies: Ashley Ross, MD, Ph.D., Associate Professor,...

Gender Differences in Bladder Cancer - Lauren Cooley

Details
Lauren Cooley joins Alicia Morgans for a discussion on gender differences in bladder cancer. Men are far more likely to be diagnosed with bladder cancer compared to women. Yet when women are diagnosed with bladder cancer, they are usually older and their disease is more advanced. Dr. Cooley explains how her research uses a mouse model to explore potential genetic and immunologic differences in the...

Adjuvant Therapy after Nephroureterectomy for High-Risk Upper Tract Urothelial Carcinoma - Sima Porten

Details
Sam Chang interviews Sima Porten focusing on upper tract urothelial carcinoma. Dr. Porten emphasizes the crucial role of urologists as gatekeepers in disease management and the importance of adjuvant therapy for high-risk patients. She highlights the significant impact of adjuvant chemotherapy on event-free survival, citing the POUT data. The conversation explores the challenges of choosing betwee...